Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Name
Syed A. A. Rizvi, MD, PhD(Pharm), PhD(Chem), MSc, MBA, MS
Title
Faculty
Bio
Dr. Rizvi earned bachelor of Science (B.Sc) and Master of Science degrees from the University of Karachi, with expertise in Organic and Natural Product Chemistry. After earning an M.Sc, Dr. Rizvi came to US to pursue an M.S and Ph.D combined degree program at the Center for Biotechnology and Drug Design, Department of Chemistry, Georgia State University (GSU), Atlanta, GA. While working at GSU, Dr. Rizvi was trained in the areas of Analytical Chemistry, Separation Sciences, Bioanalysis, Surfactant Chemistry, Chiral Separations of the Drugs, Trace Level Analysis (Forensic Chemistry) of Drugs in human body fluids (led to a US and International patent).
Right after finishing M.S and Ph.D at the GSU, Dr. Rizvi pursued another Ph.D (under Prof. Martin J. D’Souza) at the College of Pharmacy and Health Sciences, Department of the Pharmaceutical Sciences, Mercer University (MU), Atlanta, GA in collaboration with Dr. Scott L Childs (founder and chief Scientific officer, Renovo Research, LLC). At Mercer, Dr. Rizvi was trained in the areas of Solid Dosage Formulations (direct compressed tablets), Controlled Release Formulations, Nanoparticulate System for Non-Invasive real time In Vivo Imaging, Cell-Lipid interaction Studies. At Renovo, Dr. Rizvi was trained in the area of Solid State Chemistry of the Drugs, e.g., Polymorphism and Cocrystallization .
Dr. Rizvi has Published over 250 peer reviewed articles that including, 51 journal papers, 48 oral and poster presentation abstracts, 2 book chapters, 1 text book, and 1 US patent (US8168440). Dr. Rizvi also presents his work through posters and oral presentations in national and international conferences. Dr. Rizvi serves as editor-in-chief, associate editor, executive editor and editorial board member for 35 different journals (various capacities) and review manuscripts and books for 76 well known scientific publications (journals and books).
Right after finishing M.S and Ph.D at the GSU, Dr. Rizvi pursued another Ph.D (under Prof. Martin J. D’Souza) at the College of Pharmacy and Health Sciences, Department of the Pharmaceutical Sciences, Mercer University (MU), Atlanta, GA in collaboration with Dr. Scott L Childs (founder and chief Scientific officer, Renovo Research, LLC). At Mercer, Dr. Rizvi was trained in the areas of Solid Dosage Formulations (direct compressed tablets), Controlled Release Formulations, Nanoparticulate System for Non-Invasive real time In Vivo Imaging, Cell-Lipid interaction Studies. At Renovo, Dr. Rizvi was trained in the area of Solid State Chemistry of the Drugs, e.g., Polymorphism and Cocrystallization .
Dr. Rizvi has Published over 250 peer reviewed articles that including, 51 journal papers, 48 oral and poster presentation abstracts, 2 book chapters, 1 text book, and 1 US patent (US8168440). Dr. Rizvi also presents his work through posters and oral presentations in national and international conferences. Dr. Rizvi serves as editor-in-chief, associate editor, executive editor and editorial board member for 35 different journals (various capacities) and review manuscripts and books for 76 well known scientific publications (journals and books).
